Login
$VXRT
$0.50 +$0.00 (0.51%) Close

Company Executives

$VXRT Management Team

Dr. Michael Finney

Chairman of the Board

Age 66
Compensation $305.4K USD
Sex Male

Mr. Steven Lo

President

Chief Executive Officer

Director

Age 58
Compensation $2.086M USD
Sex Male

Mr. Jeroen Grasman

Chief Financial Officer

Principal Accounting Officer and Principal Financial Officer

Age -
Compensation -
Sex Male

Dr. Sean Tucker

Senior Vice President

Chief Scientific Officer

Age 57
Compensation $1.155M USD
Sex Male

Mr. Edward Berg

Senior Vice President

General Counsel

Age 61
Compensation -
Sex Male

Ms. Laurie Hastings

Senior Vice President of Human Resources

Age -
Compensation -
Sex Female

Dr. James Cummings

Chief Medical Officer

Age 59
Compensation $1.213M USD
Sex Male

Mr. Matt Stein

IR Contact Officer

Age -
Compensation -
Sex Male
Directors
6
serving now
Independent
5 of 6
stated in the proxy
Average tenure
3.0 years
from year joined
CEO also chairs the board
No
Michael J. Finney
Director Age On board Independent Committees Other public boards 2024 pay Source
Kevin P. Finney
57 2025
0 years
Independent
Audit Committee
None stated Not stated
Michael J. Finney
66 2018
7 years
Independent None stated None stated Not stated
Elaine J. Heron, Ph.D.
77 2022
3 years
Independent
Compensation Committee
BioMarin Pharmaceutical Inc. $143,779
Steven Lo
58 2024
1 year
Not independent None stated None stated Paid as CEO
W. Mark Watson
74 2022
3 years
Independent
Audit Committee · Chair
None stated $142,881
David Wheadon, M.D.
67 2021
4 years
Independent None stated None stated $146,976

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

3 disclosed in the proxy filed Apr 10, 2025
executive officers and directors
executive officers and directors of the Company
Amount not stated

Indemnity agreements under which the Company will indemnify and advance expenses to executive officers and directors.

Mr. Floroiu
former President and Chief Executive Officer
Amount not stated

Separation Agreement entered into on January 31, 2024 with the former President and Chief Executive Officer.

executive officers and members of our board of directors
executive officers and members of our board of directors
Amount not stated

Grants of stock options to executive officers and board members.

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support